| Literature DB >> 31763103 |
Michael Yan1, Richard Gregg2, Aamer Mahmud3.
Abstract
Metastatic renal cell carcinoma (mRCC) is associated with a poor prognosis. It is traditionally a treatment-resistant disease necessitating multi-modal treatment and close follow-up. We herein report a case of mRCC in a patient who was managed closely by a multi-disciplinary team and still retained a very good performance status and treatment response three years after diagnosis. We highlight the importance of close monitoring, switching systemic therapies at progression, early palliative radiotherapy, and patient education in controlling disease burden and maintaining quality of life in patients with mRCC.Entities:
Keywords: metastatic disease; multi-disciplinary; palliative care; radiotherapy; renal cell carcinoma
Year: 2019 PMID: 31763103 PMCID: PMC6850746 DOI: 10.7759/cureus.5901
Source DB: PubMed Journal: Cureus ISSN: 2168-8184